Core Insights - China has become a global growth hub for humanoid robots, with a market size projected to reach 8.239 billion yuan by 2025, accounting for nearly 50% of the global market share, and an industry growth rate exceeding 50% [1] - The industry is transitioning from "technology validation" to "scale production" by 2026, with global shipments expected to exceed 50,000 units, marking a 700% year-on-year increase [1] - A clear structure has emerged in the domestic market, with listed companies solidifying production capabilities and pre-IPO companies targeting niche segments [1] Listed Companies - Tuosida (300607.SZ): A leading player in the industrial sector, planning to issue H shares for international expansion, with a focus on technology R&D and supply chain upgrades [1] - UBTECH (09880.HK): Recently listed in December 2023, it aims to enhance its supply chain through acquisitions and is positioned in the first tier of domestic humanoid robot companies [2] - Siasun (300024.SZ): A state-owned enterprise recognized for its industrial precision applications, leveraging government support for technology development [2] - Estun (002747.SZ): Focused on industrial precision tasks, it has established a strong position in the second tier of listed companies [3] Pre-IPO Companies - Yushu Technology: Positioned in the consumer humanoid robot sector, it is advancing its IPO process and ranks high among pre-IPO companies due to its cost-effective products [4] - Zhiyuan Robotics: Rapidly climbing the ranks among pre-IPO companies, it integrates AI with robotics for enhanced capabilities [4] - Yunji Technology: Aiming for a listing, it focuses on service robots and has a mature commercialization model [6] - Fourier Intelligence: Specializes in medical humanoid robots, with a strong focus on rehabilitation and clinical applications [6] Industry Trends - The domestic humanoid robot industry is characterized by high levels of technological autonomy, with over 6,618 patent applications and a core component localization rate exceeding 70% [5] - Rapid scene deployment is evident, with industrial applications achieving large-scale validation and consumer and medical sectors accelerating penetration [5] - A supportive policy and capital environment, including a comprehensive policy framework and substantial industry funds, is facilitating industry upgrades [5]
2026 国内人形机器人公司格局:上市梯队领航,拟上市力量突围